A prospective trial investigating the role of Serum 25-Hydroxyvitamin D in diagnosis and prognosis of bladder cancer.

Ahmed Abdelgawad Abdelwahab HashemAhmed MosbahLaila A Eissa

Published in: PloS one (2022)

Serum 25(OHD) is significantly decreased in BC patients especially those with tumor muscle invasive group. However, the baseline serum 25(OHD) does not predict the recurrence in the NMIBC patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
clinical trial
randomized controlled trial
skeletal muscle